Mais, Kathleen
14  Ergebnisse:
Personensuche X
?
2

Taxane, platinum and 5-FU prior to chemoradiotherapy benefi..:

Lowe, Natalie M. ; Bernstein, Jonathan M. ; Mais, Kathleen...
Journal of Cancer Research and Clinical Oncology.  144 (2017)  2 - p. 389-401 , 2017
 
?
3

A double-blind, placebo-controlled, randomised trial of act..:

Bardy, Joy ; Molassiotis, Alex ; Ryder, W. David...
British Journal of Oral and Maxillofacial Surgery.  50 (2012)  3 - p. 221-226 , 2012
 
?
4

Phase II study of cisplatin and imatinib in advanced saliva..:

Ghosal, Niladri ; Mais, Kathleen ; Shenjere, Patrick...
British Journal of Oral and Maxillofacial Surgery.  49 (2011)  7 - p. 510-515 , 2011
 
?
 
?
9

Pre-treatment tumour perfusion parameters and initial RECIS..:

Lowe, Natalie ; Kershaw, Lucy ; Bernstein, Jonathan M...
Lowe , N , Kershaw , L , Bernstein , J M , Withey , S B , Mais , K , Homer , J , Slevin , N , Bonington , S C , Carrington , B M & West , C 2018 , ' Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapy ' , P L o S One . https://doi.org/10.1371/journal.pone.0194841.  , 2018
 
?
10

Taxane, platinum and 5-FU prior to chemoradiotherapy benefi..:

Lowe, Natalie ; Bernstein, Jonathan ; Mais, Kathleen...
Lowe , N , Bernstein , J , Mais , K , Garcez , K , Lee , L W , Sykes , A , Thomson , D , Homer , J , West , C & Slevin , N 2017 , ' Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status ' , Journal of Cancer Research and Clinical Oncology . https://doi.org/10.1007/s00432-017-2553-9).  , 2017
 
?
14

Conversion of human-selective PPARα agonists to human/mouse..:

Wang, Minmin ; Winneroski, Leonard L. ; Ardecky, Robert J....
Bioorganic & Medicinal Chemistry Letters.  14 (2004)  24 - p. 6113-6116 , 2004
 
1-14